scholarly journals Improving uptake of cervical cancer screening services for women living with HIV and attending chronic care services in rural Malawi

2020 ◽  
Vol 9 (3) ◽  
pp. e000892
Author(s):  
George C Talama ◽  
Mairead Shaw ◽  
Jordan Maloya ◽  
Tafwirapo Chihana ◽  
Lawrence Nazimera ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Communicable Disease ◽  
Scale Up ◽  
Cervical Cancer Prevention ◽  
Reproductive Age ◽  
Hiv Care ◽  
Women Living With Hiv ◽  
Living With Hiv

Malawi has the second highest age-standardised incidence rate and the highest mortality rate of cervical cancer in the world. Though the prevalence of HIV is currently 11.7% for Malawian women of reproductive age, cervical cancer screening rates remain low. To address this issue, we integrated cervical cancer screening into a dual HIV and non-communicable disease clinic at a rural district hospital in Neno, Malawi. The project was implemented between January 2017 and March 2018 using the Plan-Do-Study-Act model of quality improvement (QI). At baseline (January to December 2016), only 13 women living with HIV were screened for cervical cancer. One year after implementation of the QI project, 73% (n=547) of women aged 25 to 49 years living with HIV enrolled in HIV care were screened for cervical cancer, with 85.3% of these receiving the screening test for the first time. The number of women living with HIV accessing cervical cancer services increased almost 10 times (from four per month to 39 per month, p<0.001). Key enablers in our QI process included: strong mentorship, regular provision of cervical cancer health talks throughout the hospital, nationally accredited cervical cancer prevention training for all providers, consistent community engagement, continuous monitoring and evaluation, and direct provision of resources to strengthen gaps in the public system. This practical experience integrating cervical cancer screening into routine HIV care may provide valuable lessons for scale-up in rural Malawi.

scholarly journals Understanding barriers to access and utilization of cervical cancer screening services among women living with HIV in Kyenjojo District, Western Uganda protocol

2018 ◽  
Author(s):  
Katwesige Wycliff
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Scale Up ◽  
Cervical Cancer Prevention ◽  
Women Living With Hiv ◽  
Barriers To Access ◽  
Screening Services ◽  
Living With Hiv ◽  
Hiv Aids

IntroductionCervical Cancer is preventable and ranks as the second common cancer among women globally. Since 1981, the incidence of cervical cancer has been on the rise among women living with HIV/AIDS. Cervical cancer in Uganda is usually diagnosed late and the prognosis is very poor. There are gaps in general knowledge on cervical cancer (CC) screening and availability of screening services in the country. This study is intended to explore such barriers to access and utilization of cervical cancer screening services among WHIV in Kyenjojo DistrictMethodologyWe will search publications and written articles on cervical cancer prevention especially screening among HIV women, from PubMed, Cochrane libraries, as well as the ministry of health unpublished reports. We will employ a qualitative study design using key informant (KI) purposively selected from Kyenjojo Hospital Reproductive Health and ART Clinics. This will permit us to achieve a detailed investigation using health belief model on individual perceptions while providing deeper insights into the factors that hinder access and utilization of cervical cancer screening services among HIV/AIDS women in Kyenjojo District. ConclusionThis study is intended to explore such barriers to access and utilization of cervical cancer screening services among WHIV in Kyenjojo. The study will thus significantly contribute to improved programming, advocacy, and efforts to scale up CC services among rural populations in Uganda while contributing to overall maternal survival in line with 2030 Sustainable Development Goals country initiatives

scholarly journals Impact of cervicitis on performance of cervical cancer screening using HRHPV testing and visual evaluation in women living with HIV in Botswana

2020 ◽  
Vol 151 (1) ◽  
pp. 144-146
Author(s):  
Helena Painter ◽  
Adrienne Erlinger ◽  
Boikhutso Simon ◽  
Chelsea Morroni ◽  
Doreen Ramogola‐Masire ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Visual Evaluation ◽  
Women Living With Hiv ◽  
Living With Hiv

scholarly journals Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa

2018 ◽  
Vol 79 (2) ◽  
pp. 195-205 ◽  
Author(s):  
Nicole G. Campos ◽  
Naomi Lince-Deroche ◽  
Carla J. Chibwesha ◽  
Cynthia Firnhaber ◽  
Jennifer S. Smith ◽  
...  
Keyword(s):  
South Africa ◽  
Cervical Cancer ◽  
Cost Effectiveness ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Women Living With Hiv ◽  
Living With Hiv

scholarly journals Comprehensive knowledge and uptake of cervical cancer screening is low among women living with HIV/AIDS in Northwest Ethiopia

2017 ◽  
Vol 4 (1) ◽  
Author(s):  
Daniel Asfaw Erku ◽  
Adeladlew Kassie Netere ◽  
Amanual Getnet Mersha ◽  
Sileshi Ayele Abebe ◽  
Abebe Basazn Mekuria ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Northwest Ethiopia ◽  
Women Living With Hiv ◽  
Comprehensive Knowledge ◽  
Living With Hiv ◽  
Hiv Aids

scholarly journals Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study

PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0248832
Author(s):  
Angela Devine ◽  
Alice Vahanian ◽  
Bernard Sawadogo ◽  
Souleymane Zan ◽  
Fadima Yaya Bocoum ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Burkina Faso ◽  
Cervical Cancer Screening ◽  
Visual Inspection ◽  
Screening Tests ◽  
Research Partnership ◽  
Women Living With Hiv ◽  
Screening Strategies ◽  
Living With Hiv

Introduction This study estimated the costs and incremental cost per case detected of screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+) in women living with HIV (WLHIV) attending HIV clinics in Burkina Faso. Methods The direct healthcare provider costs of screening tests (visual inspection with acetic acid (VIA), VIA combined visual inspection with Lugol’s iodine (VIA/VILI), cytology and a rapid HPV DNA test (careHPV)) and confirmatory tests (colposcopy, directed biopsy and systematic four-quadrant (4Q) biopsy) were collected alongside the HPV in Africa Research Partnership (HARP) study. A model was developed for a hypothetical cohort of 1000 WLHIV using data on CIN2+ prevalence and the sensitivity of the screening tests. Costs are reported in USD (2019). Results The study enrolled 554 WLHIV with median age 36 years (inter-quartile range, 31–41) and CIN2+ prevalence of 5.8%. The average cost per screening test ranged from US$3.2 for VIA to US$24.8 for cytology. Compared to VIA alone, the incremental cost per CIN2+ case detected was US$48 for VIA/VILI and US$814 for careHPV. Despite higher costs, careHPV was more sensitive for CIN2+ cases detected compared to VIA/VILI (97% and 56%, respectively). The cost of colposcopy was US$6.6 per person while directed biopsy was US$33.0 and 4Q biopsy was US$48.0. Conclusion Depending on the willingness to pay for the detection of a case of cervical cancer, decision makers in Burkina Faso can consider a variety of cervical cancer screening strategies for WLHIV. While careHPV is more costly, it has the potential to be cost-effective depending on the willingness to pay threshold. Future research should explore the lifetime costs and benefits of cervical cancer screening to enable comparisons with interventions for other diseases.

Sign in / Sign up

Export Citation Format

Share Document